Interactions médicamenteuses
Epirubicin + Trastuzumab deruxtecan
Gravité: Majeure
Epirubicin and Trastuzumab deruxtecan: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Trastuzumab-based therapy can cause cardiomyopathy and left ventricular dysfunction, and the risk is highest when given with anthracyclines. Epirubicin adds its own dose-related cardiotoxicity, and trastuzumab deruxtecan also carries risk of interstitial lung disease and myelosuppression.
Ce que signifie cette interaction, en termes simples
Epirubicin and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Epirubicin belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.
Pourquoi elle survient
Additive cardiotoxicity from HER2 inhibition and anthracycline-induced myocardial injury.
Conduite à tenir
Avoid concurrent use when possible and keep the interval between agents as long as practical. Check left ventricular ejection fraction before and during treatment.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Epirubicin et Trastuzumab deruxtecan, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres interactions de Epirubicin
- Adenovirus types 4 and 7 live + Epirubicin Contre-indiquée
- Belatacept + Epirubicin Majeure
- Cimetidine + Epirubicin Majeure
- Deferiprone + Epirubicin Majeure
- Dengue vaccine + Epirubicin Majeure
- Epirubicin + Etrasimod Majeure
Autres interactions de Trastuzumab deruxtecan
Questions fréquentes
Can I take Epirubicin with Trastuzumab deruxtecan?
MediHelp rates the interaction as major. Epirubicin and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Trastuzumab-based therapy can cause cardiomyopathy and left ventricular dysfunction, and the risk is highest when given with anthracyclines. Epirubicin adds its own dose-related cardiotoxicity, and trastuzumab deruxtecan also carries risk of interstitial lung disease and myelosuppression.
How serious is the interaction between Epirubicin and Trastuzumab deruxtecan?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use when possible and keep the interval between agents as long as practical. Check left ventricular ejection fraction before and during treatment.
What other medicines interact with Epirubicin?
MediHelp also lists interactions of Epirubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cimetidine. The full list is on the Epirubicin page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
